175 related articles for article (PubMed ID: 8592147)
1. Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease.
Clements A; Allsop D; Walsh DM; Williams CH
J Neurochem; 1996 Feb; 66(2):740-7. PubMed ID: 8592147
[TBL] [Abstract][Full Text] [Related]
2. Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.
Clements A; Walsh DM; Williams CH; Allsop D
Neurosci Lett; 1993 Oct; 161(1):17-20. PubMed ID: 7902973
[TBL] [Abstract][Full Text] [Related]
3. The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptide.
El-Agnaf OM; Guthrie DJ; Walsh DM; Irvine GB
Eur J Biochem; 1998 Sep; 256(3):560-9. PubMed ID: 9780232
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effects of pH, Cu+2 and sheet breakers on aggregation of amyloid peptides.
Beking K; Hao X; Basak S; Basak A
Protein Pept Lett; 2005 Feb; 12(2):197-202. PubMed ID: 15723646
[TBL] [Abstract][Full Text] [Related]
5. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
6. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
McLaurin J; Fraser PE
Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
[TBL] [Abstract][Full Text] [Related]
7. The effect of β-sheet breaker peptides on metal associated Amyloid-β peptide aggregation process.
Stellato F; Fusco Z; Chiaraluce R; Consalvi V; Dinarelli S; Placidi E; Petrosino M; Rossi GC; Minicozzi V; Morante S
Biophys Chem; 2017 Oct; 229():110-114. PubMed ID: 28527974
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's beta-amyloid peptide: affinity for metal chelates.
Balakrishnan R; Parthasarathy R; Sulkowski E
J Pept Res; 1998 Feb; 51(2):91-5. PubMed ID: 9516042
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide.
Paul A; Nadimpally KC; Mondal T; Thalluri K; Mandal B
Chem Commun (Camb); 2015 Feb; 51(12):2245-8. PubMed ID: 25514992
[TBL] [Abstract][Full Text] [Related]
10. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
Kim W; Hecht MH
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
[TBL] [Abstract][Full Text] [Related]
11. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
12. Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease.
Syme CD; Viles JH
Biochim Biophys Acta; 2006 Feb; 1764(2):246-56. PubMed ID: 16266835
[TBL] [Abstract][Full Text] [Related]
13. pH-dependent aggregate forms and conformation of Alzheimer amyloid beta-peptide (12-24).
Abe H; Kawasaki K; Nakanishi H
J Biochem; 2002 Dec; 132(6):863-74. PubMed ID: 12473188
[TBL] [Abstract][Full Text] [Related]
14. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
15. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
16. Metal ion mediated transition from random coil to β-sheet and aggregation of Bri2-23, a natural inhibitor of Aβ aggregation.
Luczkowski M; De Ricco R; Stachura M; Potocki S; Hemmingsen L; Valensin D
Metallomics; 2015 Mar; 7(3):478-90. PubMed ID: 25633876
[TBL] [Abstract][Full Text] [Related]
17. Examining the zinc binding site of the amyloid-beta peptide.
Yang DS; McLaurin J; Qin K; Westaway D; Fraser PE
Eur J Biochem; 2000 Nov; 267(22):6692-8. PubMed ID: 11054124
[TBL] [Abstract][Full Text] [Related]
18. Electrochemistry of Alzheimer Disease Amyloid Beta Peptides.
Chiorcea-Paquim AM; Enache TA; Oliveira-Brett AM
Curr Med Chem; 2018; 25(33):4066-4083. PubMed ID: 29446720
[TBL] [Abstract][Full Text] [Related]
19. Mutations enhance the aggregation propensity of the Alzheimer's A beta peptide.
Kim W; Hecht MH
J Mol Biol; 2008 Mar; 377(2):565-74. PubMed ID: 18258258
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes.
Terzi E; Hölzemann G; Seelig J
Biochemistry; 1994 Jun; 33(23):7434-41. PubMed ID: 8003508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
